May 11, 2021

EksoNR 400x275Ekso Bionics Holdings, which develops exoskeleton technology for medical and industrial usages, has announced expanding its partnership with Kindred Healthcare. The expansion will bring EksoNR, its robotic exoskeleton, to four of Kindred’s long-term acute care (LTAC) hospitals in the U.S. The multi-unit order follows a successful pilot program of the EksoNR last year, the company said.

The EksoNR helps drive patient outcomes in neurorehabilitation through early mobility and gait training. In 2019, Kindred executed a proof of concept in the Houston LTAC market, and after a successful implementation, launched three additional Ekso programs in the Houston metropolitan area in 2020. The recent addition of acute inpatient rehabilitation units (ARUs) to select LTAC hospitals across the country offers a unique continuum of care designed to help patients recover from debilitating effects of an acute injury, impairment, or illness such as stroke, brain injury, spinal cord injury, orthopedic injury, neurological conditions, amputation, and trauma, the company said.

EksoBionics Walking275pxThe new LTAC locations using the EksoNR technology will be at Kindred’s Florida hospitals in Green Cove Springs, Tampa / St. Petersburg, Fort Lauderdale, and Melbourne. “We are excited to expand our partnership with Ekso Bionics and build on our leadership position in acute patient services with the addition of these innovative EksoNR devices,” said Mike Warrington, president of Kindred Healthcare’s hospital division. “The EksoNR, combined with its specialized gait training,  has proven to deliver game-changing results in helping patients relearn how to walk following a devastating stroke, brain injury, or spinal cord injury. Bringing the latest cutting-edge exoskeleton technology to our LTAC hospitals reinforces our commitment to patient care.”

The EksoNR device includes features such as posture and clinician control, SmartAssist software, adaptive gait training, and pre-ambulatory tools that help patients mobilize earlier to restore their independence.

“Our robust partnership and this multi-unit order with Kindred are a testament to our shared goals and patient-driven values,” said Jack Peurach, CEO and president of Ekso Bionics. “As the first network to explore the benefits of EksoNR in the LTAC setting, Kindred has always been at the forefront of patient care. We look forward to continue advancing our relationship throughout the Kindred network.”

The company has listed locations where EksoNR is being used at this website.